BIO Deutschland Member Directory

Regensburg, Germany

The 2bind GmbH is a service provider in the field of biophysical analyses. Their customers and collaborators mainly work in the fields of drug development, aptamer generation, and antibody discovery. They offer different assays formats 1. They analyze protein stability using the nanoDSF technology: This labelfree method allows them to determine the melting temperature of a target protein in a precise manner with freedom of buffer and low sample consumption nanoDSF Assay formats are: -...

3B Pharmaceuticals GmbH

Berlin, Germany

3B Pharmaceuticals GmbH (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. The company is active in peptide discovery and optimization and 3BP has built a technology platform extending from hit identification to early clinical development. Technologies are applied to both in-house and collaborative R&D.

4SC AG

Planegg-Martinsried, Germany

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises three key drug candidates in various stages of preclinical and clinical development: resminostat, domatinostat (4SC-202) and 4SC-208.

AB Enzymes GmbH

Darmstadt, Germany

AB Enzymes develops and distributes enzymes. The products range from food enzymes for baking and beverages to enzymes for animal feed, textile technology and the detergents industry. AB Enzymes’ focus in the biofuel market is in the use of lignocellulosic biomass to produce transport fuels.

AbbVie Deutschland GmbH & Co. KG

Wiesbaden, Germany

AbbVie is a global, research-based biopharmaceutical company. The company's mission is to develop and market therapies that address some of the complex and serious diseases. In Germany, new drugs are being researched and developed, many aspects of clinical trials are coordinated here and they produce medicines for 60 countries. AbbVie Deutschland GmbH & Co. KG performs all steps of drug development and production, from early research to the development to marketing approval.

Abviris Deutschland GmbH

Ammersbek, Germany

Abviris' mission is the development, production and marketing of in-vitro diagnostics and medical devices in order to avoid or cure negative medical impact of human papilloma virus to patients. The company's Prevo-Check® is an in vitro diagnostic tool and represents the world's first commercially available method for specific screening for the detection of HPV-related oral cavity carcinomas.

acCELLerate GmbH

Hamburg, Germany

acCELLerate GmbH develops cell based assay kits for applications in research, safety, quality control and diagnostics. The company's instaCELL bioassays are based on ready made Frozen Instant Cells which can be directly used in an assay without prior cultivation or even cell counting. The kits contain all required components, assay plates, medium, reagents, controls and cells.

Acousia Therapeutics GmbH

Tübingen, Germany

Acousia Therapeutics GmbH is a privately held biotech company which identifies small molecules for the treatment of hearing loss. The company's therapeutic approach replaces lost sensory hair cells, the key cells for hearing in the inner ear, by cellular regeneration originating from supporting cells. In addition, this therapy also focuses on the treatment of age-related decrease in hearing capacity.

acromion GmbH

Frechen, Germany

acromion GmbH is a European Clinical Research Organisation (CRO) providing full service in clinical trial organization and conduct, clinical monitoring, clinical data management, statistics and medical writing for state-of-the-art clinical trial and NIS performance. The company has conducted numerous clinical trials with a high level of complexity e.g. in oncology and the development of various biotherapeutics, first in man, early phase, and throughout product life cycles for diverse pharmaceutical,...

Adrenomed AG

Hennigsdorf, Germany

Adrenomed AG is a German privately-financed, clinical stage biopharmaceutical company. Adrenomed´s mission is to rescue vascular integrity in order to save the lives of critically ill patients with limited treatment options. The company’s lead product candidate Adrecizumab is a clinical-stage, first-in-class monoclonal antibody. Adrecizumab targets the vasoprotective peptide Adrenomedullin, an essential regulator of vascular integrity. Adrecizumab is currently under clinical evaluation in...

Aeterna Zentaris GmbH

Frankfurt, Germany

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The development and research site is based in Germany.

Affimed N.V.

Heidelberg, Germany

Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. The Company is developing single and combination therapies to treat cancers.

AGC Biologics – Heidelberg

Heidelberg, Germany

AGC Biologics is a global contract development and manufacturing organization (CDMO), dedicated to the development and manufacture of biopharmaceuticals, from pre-clinical to commercial. The company offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, using mammalian and microbial production systems.

AiCuris Anti-infective Cures GmbH

Wuppertal, Germany

AiCuris is dedicated to develop innovative drugs in the field of anti-infectives targeting severe and potentially life-threatening infectious diseases with high medical needs. The compounds represent novel chemical classes and/or act via new modes of action. Based on that AiCuris therapeutics are resistance-breaking by design. AiCuris follows a proof-of-concept strategy before out-licensing its development projects.

akampion

Berlin, Germany

akampion provides full-service public relations, investor relations and marketing communications to healthcare and technology companies. The company's services include Reputation management, strategic advice, integrated corporate communications, storytelling, public relations, investor relations, product PR, perception studies, marketing, online PR, media training and employee branding.

Alacris Theranostics GmbH

Berlin, Germany

Alacris Theranostics GmbH is a systems medicine company which is specialized in developing approaches for cancer precision medicine, biomarker discovery and drug development. The company provides next generation sequencing services for various applications, including DNA sequencing, such as whole genome and targeted sequencing; strand-specific RNA sequencing that includes RNA and mRNA sequencing; small RNA sequencing; and ChIP-Seq.

Algiax Pharmaceuticals GmbH

Erkrath, Germany

Algiax GmbH is dedicated to the discovery and development of products in the field of nervous system disease or dysfunction with main focus on neuropathic pain. Algiax’ lead candidate AP-325 is in clinical development for the treatment of neuropathic pain and acute spinal cord injury. A selection of new chemical entities (AP-4 & AP-8) is in preclinical development for the treatment of Diabetes Type 1.

altona Diagnostics GmbH

Hamburg, Germany

altona Diagnostics develops and commercializes real-time PCR based assays and molecular diagnostic test solutions in the field of infectious diseases.

amcure GmbH

Eggenstein-Leopoldshafen, Germany

amcure GmbH develops peptide active ingredients for the treatment of metastatic carcinomas. The company's lead compound, AMC303, is being developed as a potential treatment for patients with advanced and metastatic epithelial tumors, e.g. pancreatic cancer, head and neck cancer, gastric cancer, colorectal cancer, breast cancer and lung cancer. AMC303 has a high specificity for inhibiting CD44v6, a co-receptor required for signaling through multiple cellular pathways (c-Met, VEGFR-2, RON) involved...

Amgen Research (Munich) GmbH

München, Germany

Amgen is an independent biotechnology company. Amgen Research (Munich) GmbH (formerly Micromet) is part of Amgen's Research & Development. Here, biotechnology research is carried out, especially the BiTE technology and the resulting development of the bi-specific antibody.